The global Neurorehabilitation Devices market is expected to grow at a CAGR of 12.1% during the period 2024-2032. Neurorehabilitation of the central nervous system (CNS) is an important component of rehabilitation medicine.
Multiple alternatives for intervention in neurological rehabilitation include occupational therapy, electric physiotherapy, physical therapy, speech and language therapy, and other methods; new treatment methods produced enabled by modern scientific and technological progress also play an important role and are expected to boost market growth. For example, advanced brain-computer interface research has attained interactive computer game operations with fine brainwave control. Further, the ageing global population is expected to drive market growth. North America, Asia and Europe are likely to be key markets.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Neurological diseases leading to motor/cognitive impairments are major causes of adult-onset disability. While the number of people affected is over a billion, the number is likely to rise due to the quickly ageing global population. It is estimated that neurological disorders and injuries explain over six percent of the global burden of disease. With over six percent of DALY (disability-adjusted life years) across the globe, neurological disorders indicate a key widespread clinical condition. Among neurological disorders, a significant burden in DALYs is explained by cerebral-vascular disease (over fifty percent), such as stroke. Stroke and spinal cord injury (SCI), account for over fifty percent of the adult-onset disability and, more than a billion people experience some form of disability. The common lack of full recovery necessitates the development of novel neurorehabilitative treatments suited to patients and better targeting the particular disability. Such need of neurorehabilitative treatments is likely to drive the global neurorehabilitation devices market. Rehabilitation therapy may be technologically assisted by non-invasive brain stimulation, robotic-based therapy, and neural interfaces.
With time, business models develop and evolve, influencing factors include market changes and technical advancements. The neurorehabilitation devices segment is one that has been gaining much interest. Popular neurorehabilitation devices companies include:
MindMaze – Provides VR-based solution for neuro-rehabilitation; offerings include a mobile neurorehabilitation system for hospitals meant for primary motor rehabilitation and gamified neurorehabilitation system for hospital as well as home.
Nexstim – Provides non-invasive brain stimulation for rehabilitating stroke patients. The company is engaged in developing Navigated Brain Stimulation (NBS) – non-invasive, image-guided transcranial magnetic stimulation (TMS) for brain diagnostics and therapy.
MicroTransponder – A medical device development company focusing on neuroscience research; offers neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation.
ONWARD – Developer of a therapeutic device for spinal cord injuries.
Atlantic Therapeutics – Develops a non-invasive wearable device for pelvic floor strengthening and nerve stimulation products.
NeuroLutions – Develops a robotic glove controlled by the brain.
Nalu Medical – Developer of a neurostimulation system. The Nalu system is used for Spinal Cord Stimulation and Peripheral Nerve Stimulation for chronic pain treatment. Increasing activity of companies engaged in the domain is likely to drive the global neurorehabilitation devices market.
Significant progress has been made in interdisciplinary domains such as neural engineering to examine multiple neural mechanisms by identifying and processing neural signals at high spatio-temporal resolution, and by interfacing the nervous system with exterior devices, thereby restoring neurological functions lost due to disease/injury. There have also been continual technological advancements. The last few decades have witnessed a significant spread of technological approaches for human rehabilitation, such as wearable systems, brain stimulation, robots, and virtual settings. Indeed, the use of robots, virtual reality, innovative assistive devices, telerehabilitation and artificial intelligence have proven effective in enhancing patients' motor and cognitive outcomes and quality of life. For example, Ekso Bionics Holdings offers robotic exoskeleton for neurorehabilitation. Exoskeletons comprise a system of electro-mechanical devices that fit onto the extremities of the human body. Applications of such a device in the medical industry are mostly therapeutic. Indications include paralysis, neuromuscular disorders, paraplegia, stroke, spinal cord injury, and multiple sclerosis (MS).
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is classified into:
By therapy area, the market is segmented into:
By region, the market is divided into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global Neurorehabilitation Devices market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product||
|Breakup by Applications||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neurorehabilitation Devices Market Overview
3.1 Global Neurorehabilitation Devices Market Historical Value (2017-2023)
3.2 Global Neurorehabilitation Devices Market Forecast Value (2024-2032)
4 Global Neurorehabilitation Devices Market Landscape
4.1 Global Neurorehabilitation Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Neurorehabilitation Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Neurorehabilitation Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Neurorehabilitation Devices Market Segmentation
6.1 Global Neurorehabilitation Devices Market by Product
6.1.1 Market Overview
6.1.2 Neurorobotic Devices
6.1.3 Brain-computer interface
6.1.4 Non-invasive Stimulators
6.1.5 Wearable Devices
6.2 Global Neurorehabilitation Devices Market by Applications
6.2.1 Market Overview
6.2.3 Multiple Sclerosis
6.2.4 Parkinson’s Disease
6.2.5 Cerebral Palsy
6.2.6 Brain and Spinal Cord Injury
6.3 Global Neurorehabilitation Devices Market by End User
6.3.1 Market Overview
6.3.2 Rehabilitation Centers
6.3.3 Hospitals and Clinics
6.3.4 Home Care
6.4 Global Neurorehabilitation Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Neurorehabilitation Devices Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Neurorehabilitation Devices Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Neurorehabilitation Devices Market
9.1 Market Share by Country
10 Latin America Neurorehabilitation Devices Market
10.1 Market Share by Country
11 Middle East and Africa Neurorehabilitation Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Biometrics Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Ectron Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 BIONIK Laboratories Corp.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Ekso Bionics
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Bioness Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Tyromotion GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Medtronic Plc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 DIH International Limited (Hocoma AG)
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Saebo Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
18 Global Neurorehabilitation Devices Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The global neurorehabilitation devices market is estimated to grow at a CAGR of 12.1% between 2024 and 2032.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Neurorehabilitation is a process which is aimed at promoting the health of the nervous system of a patient to help recovery of functions of brain and spinal cord, among others.
Neurorehabilitation improves the health of the brain and spinal cord and improves the overall health of the central nervous system which helps the patient recover from stroke.
The major drivers of the market include the increasing prevalence of neurological disorders, increasing geriatric population, rising awareness about the fatalities, and rapid development of convenient and minimally invasive devices.
The advancements in therapeutical techniques, increasing development of high-end neurorehabilitation devices, and technological advancements in the healthcare infrastructure are the key trends propelling the growth of the market.
Neurorobotics, brain-computer interface, non-invasive stimulators, and wearable devices, among others are the different products in the market.
Based on therapy area, the neurorehabilitation devices market is divided into stroke, multiple sclerosis, Parkinson's disease, and cerebral palsy, among others.
The major players in the industry are Biometrics Ltd, Kinestica d.o.o., Ectron Ltd, BIONIK Laboratories Corp., and Ekso Bionics, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.